This inventor holds 6 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Boehringer Ingelheim Vetmedica Gmbh, Other. Active years: 2015-2022.
Location History:
- Ingelheim, DE (2015 - 2016)
- Ingelheim am Rhein, DE (2018 - 2022)
Company Filing History:
4 out of 317 
2 out of 834,350 Years Active: 2015-2022
Title: Rainer Kleemann: Innovator in Heart Failure Treatment
Introduction
Rainer Kleemann is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of heart failure. With a total of 6 patents to his name, Kleemann's work has had a profound impact on therapeutic approaches for patients suffering from this condition.
Latest Patents
Kleemann's latest patents focus on innovative methods for treating asymptomatic heart failure. One of his key inventions involves the use of PDE III inhibitors, specifically pimobendan, which is administered to patients suffering from ISACHC Classification Class I heart failure. This method aims to reduce the size of the patient's heart, thereby improving their overall health. Another significant patent involves the use of pimobendan for the reduction of heart size in mammals suffering from heart failure. This invention provides a new avenue for medication preparation aimed at alleviating the symptoms associated with heart failure.
Career Highlights
Throughout his career, Rainer Kleemann has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim Vetmedica GmbH. His expertise and innovative spirit have allowed him to develop groundbreaking treatments that address critical health issues.
Collaborations
Kleemann has collaborated with esteemed colleagues such as Juergen Daemmgen and Olaf Joens. These partnerships have further enhanced his research and development efforts in the field of heart failure treatment.
Conclusion
Rainer Kleemann's contributions to the medical field, particularly in heart failure treatment, highlight his role as an influential inventor. His innovative patents and collaborations reflect his commitment to improving patient outcomes and advancing medical science.